The objective of this study was to determine the effect of a home-based exercise program on fatigue, anxiety, quality of life (QoL), and immune function of thyroid cancer patients taking thyroid hormone replacement after thyroidectomy.
Method:
This quasi-experimental study with a non-equivalent control group included 43 outpatients taking thyroid hormone replacement after thyroidectomy (22 in the experimental group and 21 in the control group). After education about the home-based exercise program, subjects in the experimental group underwent 12 weeks of aerobic, resistance, and flexibility exercise. A comparative analysis was conducted between the two groups.
Results:
Patients in the experimental group were significantly less fatigued or anxious (p < 0.01). They reported significantly improved QoL (p < 0.05) compared to those in the control group. Natural killer cell activity was significantly higher in the exercise group compared to that in the control group (p < 0.05).
Conclusion:
A home-based exercise program is effective in reducing fatigue and anxiety, improving QoL, and increasing immune function in patients taking thyroid hormone replacement after thyroidectomy. Therefore, such a home-based exercise program can be used as an intervention for patients who are taking thyroid hormone replacement after thyroidectomy.
Get full access to this article
View all access options for this article.
References
1.
ChoiJY, KangHS. 2012. [Effects of a home-based exercise program for patients with stomach cancer receiving oral chemotherapy after surgery]. J Korean Acad Nurs, 42:95–104.
2.
CellaD, LaiJS, ChangCH, PetermanA, SlavinM. 2002. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer, 94:528–538.
3.
WinninghamML, NailLM, BurkeMB, BrophyL, CimprichB, JonesLS, Pickard-HolleyS, RhodesV, St PierreB, BeckS, et al.1994. Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum, 21:23–36.
4.
HussonO, HaakHR, OranjeWA, MolsF, ReemstPH, van de Poll-FranseLV. 2011. Health-related quality of life among thyroid cancer survivors: a systematic review. Clin Endocrinol (Oxf), 75:544–554.
5.
2002 Fatigue (PDQ®): Health Professional Version. National Cancer Institute, Bethesda, MD.
6.
YoonHJ, SeokJH. 2014. Clinical factors associated with quality of life in patients with thyroid cancer. J Korean Thyroid Assoc, 7:62–69.
7.
Babenko-MouldY, AndrusyszynMA, GoldenbergD. 2004. Effects of computer-based clinical conferencing on nursing students' self-efficacy. J Nurs Educ, 43:149–155.
8.
BanduraA. 1977. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev, 84:191–215.
9.
GoldenbergD, AndrusyszynMA, IwasiwC. 2005. The effect of classroom simulation on nursing students' self-efficacy related to health teaching. J Nurs Educ, 44:310–314.
10.
MendozaTR, WangXS, CleelandCS, MorrisseyM, JohnsonBA, WendtJK, HuberSL. 1999. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer, 85:1186–1196.
11.
ZigmondAS, SnaithRP. 1983. The hospital anxiety and depression scale. Acta Psychiatr Scand, 67:361–370.
12.
KungS, RummansTA, ColliganRC, ClarkMM, SloanJA, NovotnyPJ, HuntingtonJL. 2006. Association of optimism-pessimism with quality of life in patients with head and neck and thyroid cancers. Mayo Clin Proc, 81:1545–1552.
13.
van WeertE, Hoekstra-WeebersJE, MayAM, KorstjensI, RosWJ, van der SchansCP. 2008. The development of an evidence-based physical self-management rehabilitation programme for cancer survivors. Patient Educ Couns, 71:169–190.
14.
Van GerpenRE, BeckerBJ. 2013. Development of an evidence-based exercise and education cancer recovery program. Clin J Oncol Nurs, 17:539–543.
15.
RockCL, DoyleC, Demark-WahnefriedW, MeyerhardtJ, CourneyaKS, SchwartzAL, BanderaEV, HamiltonKK, GrantB, McCulloughM, ByersT, GanslerT. 2012. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin, 62:243–274.
16.
Physical Activity Guidelines Advisory Committee 2008 Physical activity guidelines advisory committee report, 2008. U.S. Department of Health and Human Services, Washington, DC.
17.
McGriffNJ, CsakoG, GourgiotisL, LoriCG, PucinoF, SarlisNJ. 2002. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med, 34:554–564.
18.
PujolP, DauresJP, NsakalaN, BaldetL, BringerJ, JaffiolC. 1996. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab, 81:4318–4323.
19.
WangPW, WangST, LiuRT, ChienWY, TungSC, LuYC, ChenHY, LeeCH. 1999. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab, 84:4549–4553.
20.
YiKH. 2016. The Revised 2016 Korean Thyroid Association guidelines for thyroid nodules and cancers: differences from the 2015 American Thyroid Association guidelines. Endocrinol Metab (Seoul), 31:373–378.
21.
OhPJ. 2009. Correlation between mental adjustment to cancer and anxiety. J Korean Oncol Nurs, 9:23–30.
22.
LampicC, von EssenL, PetersonVW, LarssonG, SjodenPO. 1996. Anxiety and depression in hospitalized patients with cancer: agreement in patient–staff dyads. Cancer Nurs, 19:419–428.
23.
WooSH. 2014. Endoscopic-assisted total thyroidectomy via lateral keloid scar incision. Clin Exp Otorhinolaryngol, 7:338–341.
24.
WooSH. 2014. Endoscope-assisted transoral thyroidectomy using a frenotomy incision. J Laparoendosc Adv Surg Tech A, 24:345–349.
25.
WooSH. 2013. Endoscope-assisted intraoral removal of the thyroid isthmus mass using a frenotomy incision. J Laparoendosc Adv Surg Tech A, 23:787–790.
26.
WooSH, JeongHS, KimJP, ParkJJ, BaekCH. 2013. Endoscope-assisted intraoral removal of ectopic thyroid tissue using a frenotomy incision. Thyroid, 23:605–608.
27.
KimJP, ParkJJ, LeeEJ, WooSH. 2011. Intraoral removal of a thyroglossal duct cyst using a frenotomy incision. Thyroid, 21:1381–1384.
28.
JungKW, WonYJ, KongHJ, OhCM, ChoH, LeeDH, LeeKH. 2015. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat, 47:127–141.
LeeJI, KimSH, TanAH, KimHK, JangHW, HurKY, KimJH, KimKW, ChungJH, KimSW. 2010. Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea. Health Qual Life Outcomes, 8:101.
31.
ThorntonLM, AndersenBL, CarsonWE3rd. 2008. Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis. Cancer Immunol Immunother, 57:1471–1481.
32.
HussonO, NieuwlaatWA, OranjeWA, HaakHR, van de Poll-FranseLV, MolsF. 2013. Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry. Thyroid, 23:1247–1255.
33.
AlhashemiA, JonesJM, GoldsteinDP, Santa MinaD, ThabaneL, SabistonCM, ChangEK, BrierleyJD, SawkaAM. 2017. An exploratory study of fatigue and physical activity in Canadian thyroid cancer patients. Thyroid, 27:1156–1163.
34.
BuffartLM, KalterJ, SweegersMG, CourneyaKS, NewtonRU, AaronsonNK, JacobsenPB, MayAM, GalvaoDA, ChinapawMJ, SteindorfK, IrwinML, StuiverMM, HayesS, GriffithKA, LuciaA, MestersI, van WeertE, KnoopH, GoedendorpMM, MutrieN, DaleyAJ, McConnachieA, BohusM, ThorsenL, SchulzKH, ShortCE, JamesEL, PlotnikoffRC, ArbaneG, SchmidtME, PotthoffK, van BeurdenM, OldenburgHS, SonkeGS, van HartenWH, GarrodR, SchmitzKH, Winters-StoneKM, VelthuisMJ, TaaffeDR, van MechelenW, KerstenMJ, NolletF, WenzelJ, WiskemannJ, Verdonck-de LeeuwIM, BrugJ. 2017. Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev, 52:91–104.
35.
CrampF, Byron-DanielJ. 2012. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev, 11:CD006145.
36.
VigarioPS, ChachamovitzDS, CordeiroMF, TeixeiraPF, de CastroCL, de OliveiraFP, VaismanM. 2011. Effects of physical activity on body composition and fatigue perception in patients on thyrotropin-suppressive therapy for differentiated thyroid carcinoma. Thyroid, 21:695–700.
37.
VigarioPS, ChachamovitzDS, TeixeiraPF, RocqueML, SantosML, VaismanM. 2014. Exercise is associated with better quality of life in patients on TSH-suppressive therapy with levothyroxine for differentiated thyroid carcinoma. Arq Bras Endocrinol Metabol, 58:274–281.
38.
BowerJE, GanzPA, DesmondKA, RowlandJH, MeyerowitzBE, BelinTR. 2000. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol, 18:743–753.
39.
BurchettSA, HicksTP. 2006. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog Neurobiol, 79:223–246.
40.
SwainMG. 2006. Fatigue in liver disease: pathophysiology and clinical management. Can J Gastroenterol, 20:181–188.
PedersenBK, UllumH. 1994. NK cell response to physical activity: possible mechanisms of action. Med Sci Sports Exerc, 26:140–146.
43.
KaneKL, AshtonFA, SchmitzJL, FoldsJD. 1996. Determination of natural killer cell function by flow cytometry. Clin Diagn Lab Immunol, 3:295–300.
44.
AlenM, PakarinenA, HakkinenK. 1993. Effects of prolonged training on serum thyrotropin and thyroid hormones in elite strength athletes. J Sports Sci, 11:493–497.
45.
CaralisDG, EdwardsL, DavisPJ. 1977. Serum total and free thyroxine and triiodothyronine during dynamic muscular exercise in man. Am J Physiol, 233:E115–118.
46.
ChicharroJL, HoyosJ, BandresF, TerradosN, FernandezB, LuciaA. 2001. Thyroid hormone levels during a 3-week professional road cycling competition. Horm Res, 56:159–164.
47.
PakarinenA, HakkinenK, AlenM. 1991. Serum thyroid hormones, thyrotropin and thyroxine binding globulin in elite athletes during very intense strength training of one week. J Sports Med Phys Fitness, 31:142–146.
